US Stock MarketDetailed Quotes

MLTX MoonLake Immunotherapeutics

Watchlist
  • 40.180
  • +1.030+2.63%
Close Apr 29 16:00 ET
  • 40.180
  • 0.0000.00%
Post 20:01 ET
2.54BMarket Cap-21.26P/E (TTM)

About MoonLake Immunotherapeutics Company

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

Company Profile

SymbolMLTX
Company NameMoonLake Immunotherapeutics
Listing DateOct 20, 2020
CEODr. Jorge Santos da Silva
MarketNASDAQ
Employees100
Fiscal Year Ends12-31
AddressDorfstrasse 29
CityZug
ProvinceZug
CountrySwitzerland
Zip Code6300
Phone41-41-510-80-22
Websitehttp://www.moonlaketx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jorge Santos da Silva
  • Chief Executive Officer and Director
  • 1.41M
  • Matthias Bodenstedt
  • Chief Financial Officer and Principal Accounting Officer
  • 1.03M
  • Dr. Kristian Reich
  • Chief Scientific Officer
  • 1.30M
  • Simon John Sturge
  • Chairman of the Board
  • 315.51K
  • Catherine Moukheibir
  • Independent Director
  • 287.51K
  • Spike Loy
  • Independent Director
  • 277.51K
  • Dr. Ramnik Xavier
  • Independent Director
  • 300.01K
  • Dr. Andrew Phillips, PhD
  • Independent Director
  • 281.01K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
11.940
Collegium Pharmaceutical
COLL
27.600
Cars.com
CARS
12.100
4
Workday
WDAY
243.390
5
eBay
EBAY
67.200
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.